CLINICAL_TRIALS withdrawal · 2016-05-05

Clinical Trial Update: Red Blood Cell Precursor Formulation to Determine Increased Production [Phase 2, Phase 3]

Phase 2/Phase 3 trial evaluating a red blood cell precursor formulation for increased production in anemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Targeted Medical Pharma | Conditions: Anemia | Phase 2, Phase 3 | Status: WITHDRAWN